↓ Skip to main content

Pazopanib: Evidence review and clinical practice in the management of advanced renal cell carcinoma

Overview of attention for article published in BMC Pharmacology and Toxicology, November 2018
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age
  • Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter
1 X user
peer_reviews
1 peer review site
facebook
1 Facebook page

Citations

dimensions_citation
19 Dimensions

Readers on

mendeley
57 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Pazopanib: Evidence review and clinical practice in the management of advanced renal cell carcinoma
Published in
BMC Pharmacology and Toxicology, November 2018
DOI 10.1186/s40360-018-0264-8
Pubmed ID
Authors

María José Méndez-Vidal, Áurea Molina, Urbano Anido, Isabel Chirivella, Olatz Etxaniz, Eva Fernández-Parra, Marta Guix, Carolina Hernández, Julio Lambea, Álvaro Montesa, Álvaro Pinto, Silverio Ros, Enrique Gallardo

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 57 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 57 100%

Demographic breakdown

Readers by professional status Count As %
Student > Master 10 18%
Researcher 8 14%
Librarian 3 5%
Other 3 5%
Student > Bachelor 3 5%
Other 11 19%
Unknown 19 33%
Readers by discipline Count As %
Medicine and Dentistry 13 23%
Biochemistry, Genetics and Molecular Biology 5 9%
Pharmacology, Toxicology and Pharmaceutical Science 4 7%
Chemistry 4 7%
Social Sciences 3 5%
Other 11 19%
Unknown 17 30%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 30 March 2020.
All research outputs
#14,432,184
of 23,116,036 outputs
Outputs from BMC Pharmacology and Toxicology
#205
of 445 outputs
Outputs of similar age
#236,083
of 437,588 outputs
Outputs of similar age from BMC Pharmacology and Toxicology
#8
of 15 outputs
Altmetric has tracked 23,116,036 research outputs across all sources so far. This one is in the 35th percentile – i.e., 35% of other outputs scored the same or lower than it.
So far Altmetric has tracked 445 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.3. This one is in the 49th percentile – i.e., 49% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 437,588 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 43rd percentile – i.e., 43% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 15 others from the same source and published within six weeks on either side of this one. This one is in the 46th percentile – i.e., 46% of its contemporaries scored the same or lower than it.